je.st
news
AstraZeneca cancer pipeline seen as draw for Pfizer
2014-04-21 14:25:41| Biotech - Topix.net
Pfizer may come back to bid for British drug company AstraZeneca after its reported 60 billion pound takeover approach was rejected, since a deal could make sense for the U.S. pharmaceuticals giant as it seeks to build up its cancer franchise.
Tags: cancer
draw
pipeline
pfizer
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|